MedTrace Logo

Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

NCT05654675 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-01-29

No results posted yet for this study

Summary

The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are:

* Is the new quantification method superior with respect to the method currently used in the clinic?
* Does the new quantification method provide accurate assessment of the sugar consumption of tumours?

Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.

Conditions

Interventions

DIAGNOSTIC_TEST

FDG PET/CT

Besides the standard care FDG PET/CT examination, subjects receive a dynamic whole body PET/CT examination.

Sponsors & Collaborators

  • Academisch Ziekenhuis Maastricht

    lead OTHER

Principal Investigators

  • Roel Wierts, PhD · Medical physicist

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-04-01
Completion
2025-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05654675 on ClinicalTrials.gov